C24D10.3

Caenorhabditis elegans

Enriched in intestine based on microarray studies. Is affected by elli-1 based on microarray studies. Is affected by Acrylamide based on microarray studies.

F17C11.26

Caenorhabditis elegans

Enriched in intestine based on microarray studies. Is affected by sir-2.1 based on microarray studies. Is affected by Cholestanol and nitroguanidine based on microarray studies.

Y59E1A.4

Caenorhabditis elegans

Enriched in muscle cell based on microarray studies. Is affected by sir-2.1 based on microarray studies. Is affected by fluoranthene and Sirolimus based on microarray studies.

C05A9.4

Caenorhabditis elegans

Is affected by ifo-1 based on microarray studies. Is affected by Oligosaccharides based on microarray studies.

F08B12.7

Caenorhabditis elegans

Is affected by pmt-2 based on microarray studies. Is affected by Oligosaccharides based on microarray studies.

F46A9.9

Caenorhabditis elegans

Is affected by ifo-1 based on microarray studies. Is affected by Cry5B based on microarray studies.

srx-94

Caenorhabditis elegans

Is affected by sir-2.1 based on microarray studies. Is affected by nitroguanidine based on microarray studies.

T27C5.16

Caenorhabditis elegans

Is affected by clk-1 based on microarray studies. Is affected by Progesterone based on microarray studies.

Y38E10A.35

Caenorhabditis elegans

Is affected by sir-2.1 based on microarray studies. Is affected by Atrazine based on microarray studies.

ZK836.11

Caenorhabditis elegans

Is affected by ifo-1 based on microarray studies. Is affected by Oligosaccharides based on microarray studies.